Lab Bivona

August 9, 2016

A combined chemical–genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma

Lab Bivona

August 9, 2016

Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987817"target="_blank

Newer PostPreclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancer.

Older PostAXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas